BioVie, Inc. (BIVI)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about BioVie, Inc. (BIVI)
Go deeper and ask any question about BIVI
Company Performance
Current Price
as of Sep 13, 2024$3.16
P/E Ratio
N/A
Market Cap
$19.33M
Description
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
Metrics
Overview
- HQCarson City, NV
- SectorHealth Technology
- IndustryBiotechnology
- TickerBIVI
- Price$3.16-0.32%
Trading Information
- Market Cap$19.33M
- Float60.27%
- Average Daily Volume (1m)91,714
- Average Daily Volume (3m)477,852
- EPS-$9.62
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$8.07M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$7.68M
- EV$1.75M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account